Ironwood to Acquire VectivBio for $1B in Late-stage Digestive Therapy Deal
The $1 billion acquisition deal is set to advance Ironwood’s vision of becoming the leading gastrointestinal healthcare company. Ironwood Pharmaceuticals,
Read moreThe $1 billion acquisition deal is set to advance Ironwood’s vision of becoming the leading gastrointestinal healthcare company. Ironwood Pharmaceuticals,
Read moreEisai Co., Ltd. revealed that it has partnered with Bliss Biopharmaceutical (Hangzhou) Co., Ltd. to develop BB-1701, an antibody-drug conjugate
Read moreGSK has entered into an agreement to acquire BELLUS Health, a Canadian late-stage biopharmaceutical company, for a total consideration of
Read moreTZIELD, the first disease-modifying medication to postpone Stage 3 type 1 diabetes (T1D), will be added to Sanofi’s portfolio following
Read morePharma giant Pfizer and American biotech company Seagen officially announced on Monday that they have reached a conditional merger agreement
Read moreThe worldwide product rights for the Astelas’ top systemic antifungal agent Mycamine® (micafungin sodium, known as Funguard® in Japan) have
Read moreThe acquisition agreement is set to expand Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing. Aegis Sciences
Read moreLonza and Context Therapeutics, a US-based clinical-stage biopharmaceutical company advancing therapeutics for solid tumors, announced that they have reached a
Read moreBoehringer Ingelheim and Click Therapeutics announced on December 19, that they will expand their existing collaboration to develop and commercialize
Read moreBiosynth Carbosynth, critical materials supplier to the life science industry, has announced the signing of an agreement to acquire EUCODIS
Read more